Ultrasonography-Based Measurements of Endometrial Thickness in Patients With p53 Abnormal Endometrial Carcinomas
Endometrial thickness assessed by TVUS does not appear to be a reliable screening method in patients diagnosed with p53abn endometrial cancers. The use of endometrial thickness as a screening test for endometrial cancer may miss a significant portion of p53abn cases because of false-negative results. In the presence of postmenopausal bleeding, endometrial tissue sampling should be strongly considered.
Authors
- Rachel Mojdehbakhsh
- Mary J. Kao (ORCID: https://orcid.org/0000-0003-1629-320X)
- Dandi Huang (ORCID: https://orcid.org/0000-0002-5359-9681)
- Ahmed Al‐Niaimi (ORCID: https://orcid.org/0000-0001-9767-6274)
- Lisa Barroilhet (ORCID: https://orcid.org/0000-0001-9315-2414)
- Matthew K. Wagar (ORCID: https://orcid.org/0000-0003-2300-404X)
- Amy L. Godecker (ORCID: https://orcid.org/0000-0001-8681-7385)
- Stephanie M. McGregor (ORCID: https://orcid.org/0000-0002-7940-1143)
- Eric Reetz
- Natalia Gontarczyk Uczkowski (ORCID: https://orcid.org/0009-0005-2919-2805)
Institutions
- Gynecologic Oncology Group (US)
- Memorial Sloan Kettering Cancer Center (US)
Publication Details
- Journal
- Obstetrics and Gynecology
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1097/aog.0000000000006074
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00